Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advanced Tumour Diseases”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT01671332
What this trial is testing

Docetaxel +/- Suramin in 2nd Line Advanced Non-Small Cell Lung Cancer

Who this might be right for
Carcinoma, Non Small Cell Lung
University of Wisconsin, Madison 80
Not applicableLooking for participantsNCT07288632
What this trial is testing

Effects of Genomic Profiles on Thromboembolic Risk in Patients With Locally Advanced or Metastatic Non-small-cell Lung Cancer

Who this might be right for
Venous Thromboembolism (VTE)NSCLC (Advanced Non-small Cell Lung Cancer)
University Of Perugia 500
Large-scale testing (Phase 3)Study completedNCT01500993
What this trial is testing

Capecitabine in the Perioperative Treatment of Rectal Cancer

Who this might be right for
Rectal Cancer
Universitätsmedizin Mannheim 401
Large-scale testing (Phase 3)Study completedNCT02872116
What this trial is testing

Efficacy Study of Nivolumab Plus Ipilimumab or Nivolumab Plus Chemotherapy Against Chemotherapy in Stomach Cancer or Stomach/Esophagus Junction Cancer

Who this might be right for
Gastric CancerGastroesophageal Junction CancerEsophageal Adenocarcinoma
Bristol-Myers Squibb 2,031
Testing effectiveness (Phase 2)Looking for participantsNCT04996121
What this trial is testing

XZP-5955 Tablets in Patients With NTRK or ROS1 Fusion Positive Locally Advanced or Metastatic Solid Tumors

Who this might be right for
Locally Advanced or Metastatic Solid TumorsLocally Advanced or Metastatic Non-small Cell Lung Cancer
Xuanzhu Biopharmaceutical Co., Ltd. 360
Testing effectiveness (Phase 2)UnknownNCT04828616
What this trial is testing

Study of DP303c Injection in Patients With Advanced Ovarian Cancer

Who this might be right for
Ovarian Cancer
CSPC ZhongQi Pharmaceutical Technology Co., Ltd. 104
Not applicableUnknownNCT05002452
What this trial is testing

Observational Study of Factors Predicting Therapeutic Effects and Clinical Prognosis After HAIC for Locally Advanced HCC

Who this might be right for
Hepatocellular Carcinoma
Sun Yat-sen University 150
Testing effectiveness (Phase 2)Active Not RecruitingNCT05816252
What this trial is testing

SKB264 (MK-2870; Sac-TMT) for the Treatment of Participants With Advanced or Metastatic Non-small Cell Lung Cancer (SKB264-II-04) (MK-2870-003)

Who this might be right for
Non-small Cell Lung Cancer
Klus Pharma Inc. 356
Early research (Phase 1)Ended earlyNCT05395052
What this trial is testing

FT536 Monotherapy and in Combination With Monoclonal Antibodies in Advanced Solid Tumors

Who this might be right for
Non Small Cell Lung CancerColorectal CancerBreast Cancer+4 more
Fate Therapeutics 5
Early research (Phase 1)Study completedNCT06846099
What this trial is testing

Evaluate the Safety, Tolerability, Pharmacokinetics, Efficacy and Indications of RP903

Who this might be right for
Ovarian CancerCervical CancerEndometrial Cancer+2 more
Risen (Suzhou) Pharma Tech Co., Ltd. 69
Not applicableUnknownNCT06349044
What this trial is testing

A Randomized, Multicenter Phase II Basket Study of Hypofractionated Radiotherapy/Stereotactic Body Radiotherapy Followed by Immunotherapy-Based Systemic Therapy +/- L. Rhamnosus M9 for the First-Line Treatment of Advanced Digestive System Malignancies.

Who this might be right for
Her-2 Negative Adenocarcinoma of the Gastro-oesophageal Junction/Gastric AdenocarcinomaHepatocellular CarcinomaBiliary Tract Carcinoma+1 more
Zhejiang Cancer Hospital 120
Early research (Phase 1)Ended earlyNCT01744171
What this trial is testing

Vaccine Therapy in Treating Patients With Advanced Stage III-IV Melanoma

Who this might be right for
Recurrent MelanomaStage IIIB Skin MelanomaStage IIIC Skin Melanoma+1 more
Roswell Park Cancer Institute 10
Large-scale testing (Phase 3)Study completedNCT02546934
What this trial is testing

ABX Plus Cisplatin Versus Gemcitabine Plus Cisplatin in Triple Negative Breast Cancer (TNBC)

Who this might be right for
Breast Cancer
Fudan University 254
Testing effectiveness (Phase 2)Ended earlyNCT01149434
What this trial is testing

Study of JI-101 in Patients With Advanced Low Grade Endocrine Tumors, Ovarian Cancers or K-RAS Mutant Colon Cancers

Who this might be right for
CancerNeuroendocrineOvarian Cancer+1 more
University of Utah 19
Early research (Phase 1)Active Not RecruitingNCT04898634
What this trial is testing

JNJ-78278343, a T-Cell-Redirecting Agent Targeting Human Kallikrein 2 (KLK2), for Advanced Prostate Cancer

Who this might be right for
Prostatic Neoplasms
Janssen Research & Development, LLC 216
Post-approval studies (Phase 4)Study completedNCT02248571
What this trial is testing

Patient Preference for Everolimus in Combination With Exemestane or Capecitabine in Combination With Bevacizumab

Who this might be right for
Breast Cancer RecurrentHER2/Neu-negative Carcinoma of BreastHormone Receptor Positive Malignant Neoplasm of Breast
iOMEDICO AG 85
Testing effectiveness (Phase 2)Looking for participantsNCT07468071
What this trial is testing

Rollover Study for Participants Who Have Been Treated With and Are Continuing to Benefit From Opnurasib as a Single Agent or in Combination With Other Study Treatments

Who this might be right for
Locally Advanced or Metastatic KRAS G12C-mutated Non-small Cell Lung CancerAdvanced Solid Tumors Harboring the KRAS G12C Mutation
Novartis Pharmaceuticals 40
Testing effectiveness (Phase 2)Ended earlyNCT00096109
What this trial is testing

Tanespimycin in Treating Women With Refractory Locally Advanced or Metastatic Breast Cancer

Who this might be right for
Recurrent Breast CancerStage IIIB Breast CancerStage IIIC Breast Cancer+1 more
National Cancer Institute (NCI) 11
Large-scale testing (Phase 3)Ended earlyNCT02129699
What this trial is testing

Survival imProvement in Lung cancEr iNduced by DenOsUmab theRapy

Who this might be right for
Lung Cancer Non-small Cell Stage IV
ETOP IBCSG Partners Foundation 595
Post-approval studies (Phase 4)Study completedNCT02744664
What this trial is testing

Cryotherapy Combine Icotinib for Advanced NSCLC Treatment

Who this might be right for
Lung Neoplasms
Fuda Cancer Hospital, Guangzhou 60
Next Page